Skip to content

Treating Yakritodara ( Non Alcoholic Fatty Liver) with Manadya Gudika and Arogyavardhini Gutika

A RANDOMIZED, SINGLE -BLIND, CONTROLLED CLINICAL TRIAL COMPARING THE THERAPEUTIC EFFECTS OF MANADYA GUDIKA AND AROGYAVARDHINI GUTIKA IN THE MANAGEMENT OF YAKRITODARA (NON-ALCOHOLIC FATTY LIVER DISEASE) IN ADULTS - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108148
Enrollment
104
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurved DSRRAU Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Yakritodara (Non-Alcoholic Fatty Liver Disease) based on clinical laboratory and imaging findings Liver Enzymes Elevated liver enzymes (ALT AST) equalor more than 1.5 times the upper limit of normal Clinically and Sonographically diagnosed Acute case of fatty liver disease up to 2nd grade Consent Patients willing to provide informed consent Cooperation: Patients willing to cooperate with the study procedures

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Severe Liver Disease Patients with severe liver disease cirrhosis liver failure Concomitant Medications Patients taking hepatotoxic medications anticoagulants or medications that may interact with the study medications Allergies Patients with known allergies to Ayurvedic medications Comorbidities Patients with uncontrolled hypertension diabetes Hyperlipidemia or other comorbidities that may interfere with the study Alcohol Consumption Patients with a history of excessive alcohol consumption

Design outcomes

Primary

MeasureTime frame
Changes in graded of various symptoms such as Anorexia/Loss of appetite, Fatigue/Saad Yellowish colorations of eye, skin, nail, face, & urine (jaundice), Hepatic Tenderness/Vedana, Hepatomegaly/Ykarit Vriddhi and liver enzymes (ALT, AST).Timepoint: 3 Months

Secondary

MeasureTime frame
Changes in waist circumference, BMI, quality of life scores and safety parametersTimepoint: 3 Months

Countries

India

Contacts

Public ContactDr Brahmanand Sharma

Post Graduate Institute Of Ayurved DSRRAU,Jodhpur

bkmudgal9@gmail.com9460318138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026